P. Picci et al., CHEMOTHERAPY-INDUCED TUMOR NECROSIS AS A PROGNOSTIC FACTOR IN LOCALIZED EWINGS-SARCOMA OF THE EXTREMITIES, Journal of clinical oncology, 15(4), 1997, pp. 1553-1559
Purpose: This study was performed to assess the prognostic value of th
e proposed histopathologic method to evaluate the response of the prim
ary tumor to preoperative chemotherapy in Ewing's sarcoma. Patients an
d Methods: The response to chemotherapy was evaluated from the specime
ns of 118 Ewing's sarcoma patients, who were preoperatively treated by
chemotherapy alone. Responses were graded I to III (macroscopic viabl
e tumor, microscopic viable tumor, and no viable tumor cells, respecti
vely). Follow-up data were available for all patients, with a mean fol
low-up duration of 86 months (range, 30 to 158). Results: A statistica
lly highly significant difference was observed in outcome among the th
ree groups of patients. For patients with total necrosis (grade III re
sponse), the estimated 5-year disease-free survival rare was 95%, in c
ontrast to 68% for grade II responders and 34% for grade III responder
s (P < .0001). This difference was also confirmed when any single grou
p was compared with the other groups. Among the parameters rested, pat
ient age and the size of tumor had some prognostic value. Conclusion:
The proposed histopathologic grading, to evaluate the effect of chemot
herapy on the primary tumor, had the strongest correlation to clinical
outcome. This method could therefore be used to identify patients wit
h a high risk of recurrent disease. These patients could be randomized
to receive alternative postoperative treatments to investigate whethe
r more aggressive therapies will improve outcome. (C) 1997 by American
Society of Clinical Oncology.